Literature DB >> 6633587

Designs for experiments--parallel comparisons of treatment.

P W Lavori, T A Louis, J C Bailar, M Polansky.   

Abstract

Clinical trials of medical treatments often compare two treated groups or a treated group with a separate but concurrent control group. We have examined a consecutive series of 47 such parallel studies reported in the Journal in 1978-1979, including 35 with random assignment to the treated or control group, to discover how this approach is actually used. A major strength of these studies as a group was the frequent use of randomized treatment assignment. Common problems included lack of sufficient detail about methods of randomization, failure to provide enough detail about patient sources, and insufficient use of multivariate statistical techniques and of statistical modeling. We emphasize the importance of avoiding bias by balancing prognostic factors when assigning patients to treatments, reducing bias by modeling the influence of prognostic factors on response, and increasing precision by modeling. We also advocate the careful consideration of the relevance of a treatment comparison within the study to the external world of clinical practice.

Entities:  

Mesh:

Year:  1983        PMID: 6633587     DOI: 10.1056/NEJM198311243092105

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  17 in total

1.  Design of treatment trials for functional gastrointestinal disorders.

Authors:  S J Veldhuyzen van Zanten; N J Talley; P Bytzer; K B Klein; P J Whorwell; A R Zinsmeister
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Comparison of balanced and random allocation in clinical trials: a simulation study.

Authors:  M M Rovers; H Straatman; G A Zielhuis
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

3.  Development of a rational practice of therapeutics.

Authors:  M D Rawlins
Journal:  BMJ       Date:  1990-10-03

4.  Alzheimer-type dementia and verbal memory performances: influence of selegiline therapy.

Authors:  G Finali; M Piccirilli; C Oliani; G L Piccinin
Journal:  Ital J Neurol Sci       Date:  1992-03

5.  Adjusting for Baseline Covariates in Net Benefit Regression: How You Adjust Matters.

Authors:  Wanrudee Isaranuwatchai; Maureen Markle-Reid; Jeffrey S Hoch
Journal:  Pharmacoeconomics       Date:  2015-10       Impact factor: 4.981

Review 6.  A tutorial on methods to estimating clinically and policy-meaningful measures of treatment effects in prospective observational studies: a review.

Authors:  Peter C Austin; Andreas Laupacis
Journal:  Int J Biostat       Date:  2011-01-06       Impact factor: 0.968

7.  To waiver or not to waiver? The dilemma of informed consent in emergency department suicide prevention research.

Authors:  Nicole Hill; Lynette Joubert; Carol Harvey; Graeme Hawthorne
Journal:  Australas Med J       Date:  2011-08-31

8.  Using an n-of-1 trial to assist in clinical decision making for patients with orofacial pain.

Authors:  Donald R Nixdorf; Radwa Sobieh; Janne Gierthmühlen
Journal:  J Am Dent Assoc       Date:  2012-03       Impact factor: 3.634

9.  Experimental design and statistical analysis.

Authors:  P F Moodie; D B Craig
Journal:  Can Anaesth Soc J       Date:  1986-01

10.  Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.

Authors:  J H Joshi; K A Newman; B W Brown; R S Finley; R L Ruxer; M A Moody; S C Schimpff
Journal:  Support Care Cancer       Date:  1993-07       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.